-
公开(公告)号:US20060009377A1
公开(公告)日:2006-01-12
申请号:US11170967
申请日:2005-06-29
申请人: Dominique Bridon , Benoit L'Archeveque , Alan Ezrin , Darren Holmes , Anouk Leblanc , Serge Pierre
发明人: Dominique Bridon , Benoit L'Archeveque , Alan Ezrin , Darren Holmes , Anouk Leblanc , Serge Pierre
IPC分类号: A61K38/27
CPC分类号: C07K14/005 , A61K38/00 , A61K47/643 , C07K14/57563 , C07K14/605 , C12N2740/16122
摘要: Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
-
公开(公告)号:US20060058235A1
公开(公告)日:2006-03-16
申请号:US11215967
申请日:2005-08-30
申请人: Dominique Bridon , Benoit L'Archeveque , Alan Ezrin , Darren Holmes , Anouk Leblanc , Serge St. Pierre
发明人: Dominique Bridon , Benoit L'Archeveque , Alan Ezrin , Darren Holmes , Anouk Leblanc , Serge St. Pierre
IPC分类号: A61K38/22
CPC分类号: C07K14/005 , A61K38/00 , A61K47/643 , C07K14/57563 , C07K14/605 , C12N2740/16122
摘要: Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
-
公开(公告)号:US20060135426A1
公开(公告)日:2006-06-22
申请号:US11304446
申请日:2005-12-14
申请人: Dominique Bridon , Benoit L' Archeveque , Alan Ezrin , Darren Holmes , Anouk Leblanc , Serge St. Pierre
发明人: Dominique Bridon , Benoit L' Archeveque , Alan Ezrin , Darren Holmes , Anouk Leblanc , Serge St. Pierre
IPC分类号: C07K14/605 , A61K38/27
CPC分类号: C07K14/005 , A61K38/00 , A61K47/643 , C07K14/57563 , C07K14/605 , C12N2740/16122
摘要: Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
摘要翻译: 公开了改进的促胰岛素肽。 修饰的促胰岛素肽能够形成肽酶稳定的促胰岛素肽。 修饰的促胰岛素肽能够与一种或多种血液成分形成共价键以形成缀合物。 缀合物可以在体内或离体形成。 施用修饰的肽以治疗患有糖尿病和其他相关疾病的人。
-
公开(公告)号:US20050187159A1
公开(公告)日:2005-08-25
申请号:US11066697
申请日:2005-02-25
申请人: Dominique Bridon , Alan Ezrin , Peter Milner , Darren Holmes , Karen Thibaudeau
发明人: Dominique Bridon , Alan Ezrin , Peter Milner , Darren Holmes , Karen Thibaudeau
CPC分类号: C07K19/00
摘要: A method for protecting a peptide from peptidase activity in vivo, the peptide being composed of between 2 and 50 amino acids and having a C-terminus and an N-terminus and a C-terminus amino acid and an N-terminus amino acid is described. In the first step of the method, the peptide is modified by attaching a reactive group to the C-terminus amino acid, to the N-terminus amino acid, or to an amino acid located between the N-terminus and the C-terminus, such that the modified peptide is capable of forming a covalent bond in vivo with a reactive functionality on a blood component. In the next step, a covalent bond is formed between the reactive group and a reactive functionality on a blood component to form a peptide-blood component conjugate, thereby protecting said peptide from peptidase activity. The final step of the method involves the analyzing of the stability of the peptide-blood component conjugate to assess the protection of the peptide from peptidase activity.
-
公开(公告)号:US20050037974A1
公开(公告)日:2005-02-17
申请号:US10934841
申请日:2004-09-02
申请人: Alexander Krantz , Wolin Huang , Arthur Hanel , Darren Holmes , Dominique Bridon
发明人: Alexander Krantz , Wolin Huang , Arthur Hanel , Darren Holmes , Dominique Bridon
CPC分类号: A61K49/0021 , A61K38/00 , A61K47/62 , A61K47/6901 , A61K49/0043 , A61K49/0056 , C07K14/665
摘要: Methods and compositions are provided for identifying compounds having affinity or complementarity to a target molecule. Compounds according to the invention may be described by the formula E-Ca—R—Cb-A, wherein E is a therapeutic or diagnostic agent, R is a reactive group, Ca and Cb are connector groups between E and R and between R and A, respectively, and A is a group having an affinity for human serum albumin, wherein affinity group A comprises a sequence of amino acid residues —O1—O2—X1—X2—B in which the amino acid residues are independently selected from the group of all twenty naturally occurring amino acids. Compounds according to the invention may be used for labeling the target molecule, particularly where the target molecule is naturally found in a complex mixture, such as a physiological fluid, like blood. By affinity labeling in vivo, the lifetime of physiologically active entities can be greatly enhanced by becoming bound to long-lived blood components. The covalently bound entity may also serve as an antagonist or agonist of a particular binding protein or as an enzyme inhibitor.
摘要翻译: 提供了用于鉴定与靶分子具有亲和力或互补性的化合物的方法和组合物。 根据本发明的化合物可以由式E-Ca-R-Cb-A描述,其中E是治疗或诊断剂,R是反应性基团,Ca和Cb是E和R之间的连接基团,R和 A,A是对人血清白蛋白具有亲和性的基团,其中亲和基团A包含氨基酸残基-O1-O2-X1-X2-B的序列,其中氨基酸残基独立地选自 的二十种天然存在的氨基酸。 根据本发明的化合物可以用于标记靶分子,特别是当目标分子天然存在于复杂混合物如生理液体如血液中时。 通过体内亲和标记,生理活性实体的寿命可以通过与长寿命的血液成分结合而大大增强。 共价结合的实体也可以用作特异性结合蛋白的拮抗剂或激动剂或作为酶抑制剂。
-
公开(公告)号:US20080026751A1
公开(公告)日:2008-01-31
申请号:US11624480
申请日:2007-01-18
申请人: Bence Alaksza , Miguel Angel Castro , Nigel Dunne , Mark Fairbrother , Robin Anthony Foreman , Darren Holmes , Terry Peter David Stebbens , Mark G. Wildie
发明人: Bence Alaksza , Miguel Angel Castro , Nigel Dunne , Mark Fairbrother , Robin Anthony Foreman , Darren Holmes , Terry Peter David Stebbens , Mark G. Wildie
IPC分类号: H04Q7/20
摘要: There is disclosed a method and apparatus for initiating a call in a mobile telephone system, comprising the steps of: comparing a current location of a mobile terminal to at least one predetermined location; and, responsive to a location match, initiating a call from the mobile terminal to a predetermined number associated with said at least one predetermined location.
摘要翻译: 公开了一种用于在移动电话系统中发起呼叫的方法和装置,包括以下步骤:将移动终端的当前位置与至少一个预定位置进行比较; 并且响应于位置匹配,发起从所述移动终端到与所述至少一个预定位置相关联的预定数量的呼叫。
-
公开(公告)号:US08498630B2
公开(公告)日:2013-07-30
申请号:US11624480
申请日:2007-01-18
申请人: Bence Alaksza , Miguel Angel Castro , Nigel Dunne , Mark Fairbrother , Robin Anthony Foreman , Darren Holmes , Terry Peter David Stebbens , Mark G. Wildie
发明人: Bence Alaksza , Miguel Angel Castro , Nigel Dunne , Mark Fairbrother , Robin Anthony Foreman , Darren Holmes , Terry Peter David Stebbens , Mark G. Wildie
IPC分类号: H04M3/00
摘要: There is disclosed a method and apparatus for initiating a call in a mobile telephone system, comprising the steps of: comparing a current location of a mobile terminal to at least one predetermined location; and, responsive to a location match, initiating a call from the mobile terminal to a predetermined number associated with said at least one predetermined location.
摘要翻译: 公开了一种用于在移动电话系统中发起呼叫的方法和装置,包括以下步骤:将移动终端的当前位置与至少一个预定位置进行比较; 并且响应于位置匹配,发起从所述移动终端到与所述至少一个预定位置相关联的预定数量的呼叫。
-
-
-
-
-
-